Fatigue News and Research

RSS

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.

10 Feb 2013

Four-step process delivers specific, reliable clinical rules

Dutch researchers have developed a four-step strategy for formulating clinical decision support systems, which they say could help reduce “alert fatigue.”

7 Feb 2013

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) will hold a grand opening for America's first Institute for Neuro Immune Medicine on Feb. 12.

5 Feb 2013

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Gilead Sciences today announced topline results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the once-daily nucleotide sofosbuvir in combination with ribavirin (FISSION) and in combination with ribavirin and pegylated interferon (NEUTRINO) among treatment-naïve patients with chronic hepatitis C virus (HCV) infection.

5 Feb 2013

Women still underestimate the seriousness of heart disease

Although heart disease remains the No. 1 killer nationally for women-—responsible for one out of every three deaths—-many of today's women still underestimate the seriousness of the disease and their risks, says Liliana Cohen, MD, a board-certified cardiologist with The Robert Wood Johnson Medical Group.

4 Feb 2013

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Research led by Queen Mary, University of London, has shown that recovery from chronic fatigue syndrome (CFS) is possible for some patients, and has identified two treatments most likely to lead to recovery.

2 Feb 2013

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best to address the psychological needs of patients with cancer.

1 Feb 2013

Family history one of the strongest predictors of heart disease

Sherron Simmons lived her life as the picture of good health: she exercised regularly, ate healthy and did not smoke. That is why it was a shock for her to learn in 2007 that the main left artery to her heart was 90 percent blocked.

1 Feb 2013

UIC to determine whether exercise can shorten recovery time for stem cell transplant patients

Researchers at the University of Illinois at Chicago College of Nursing have received a four-year grant to determine whether exercise can shorten recovery time for patients who undergo high-dose chemotherapy and stem cell transplantation.

From Danaher 31 Jan 2013

Study analyzes nursing unit layout for improved spatial flow

In hospitals, poor floor design, storage closet clutter and crowded corridors can contribute to nurse and medical staff fatigue. These distractions can hurt patient care quality and result in higher medical costs. Now, a new Cornell University study offers a spatial solution.

31 Jan 2013

Childhood adversity raises comorbidity risk in bipolar disorder

Childhood adversity, including verbal, physical, or sexual abuse, is associated with the later development of multiple medical comorbidities in patients with bipolar disorder, researchers report.

29 Jan 2013

Sleep duration naturally waxes and wanes according to researchers at University of Sydney

There’s no need to panic if you didn’t get a solid eight hours of beauty sleep last night. According to new University of Sydney research, sleep duration naturally waxes and wanes over a period of days regardless of individual lifestyle, timing of sleep or waking, and social and environmental influences.

29 Jan 2013

Devex interviews WHO NTD department director on roadmap for eliminating 17 diseases

"Lorenzo Savioli, director of WHO's department of neglected tropical diseases, spoke to Devex from Geneva in a phone interview on Wednesday, January 23, days after WHO released a progress report on its year-old roadmap to eliminate 17 tropical diseases," Devex's "Development Newswire" blog reports.

28 Jan 2013

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

28 Jan 2013

Qigong reduces depressive symptoms and improves QOL in women with breast cancer

Researchers from The University of Texas MD Anderson Cancer Center have found qigong, an ancient mind-body practice, reduces depressive symptoms and improves quality of life in women undergoing radiotherapy for breast cancer.

28 Jan 2013

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Seattle Genetics, Inc. today presented interim results from a phase I clinical trial evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (PDA) at the American Society of Clinical Oncology (ASCO) 2013 Gastrointestinal Cancers Symposium being held January 24-26, 2013 in San Francisco, CA.

28 Jan 2013

Effective therapy needed for chronic fatigue syndrome patients

Ampligen, the first drug ever seeking approval to treat chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), recently hit another roadblock with the U.S. Food and Drug Administration (FDA).

25 Jan 2013

Neuromuscular blockade (NMB) reversal

General anesthesia is made up of three components: hypnotic medicines, to induce sleep; analgesics, or medicines to inhibit pain; and NMB agents that induce muscle relaxation. Anesthesiology professionals use NMB to relax a patient’s muscles and prevent involuntary movement that could impact surgery.

24 Jan 2013

Pomalidomide safe, effective and extends overall survival for patients with multiple myeloma

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide.

24 Jan 2013

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.

23 Jan 2013

Fatigue News and Research

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

Four-step process delivers specific, reliable clinical rules

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Women still underestimate the seriousness of heart disease

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Family history one of the strongest predictors of heart disease

UIC to determine whether exercise can shorten recovery time for stem cell transplant patients

Study analyzes nursing unit layout for improved spatial flow

Childhood adversity raises comorbidity risk in bipolar disorder

Sleep duration naturally waxes and wanes according to researchers at University of Sydney

Devex interviews WHO NTD department director on roadmap for eliminating 17 diseases

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Qigong reduces depressive symptoms and improves QOL in women with breast cancer

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Effective therapy needed for chronic fatigue syndrome patients

Neuromuscular blockade (NMB) reversal

Pomalidomide safe, effective and extends overall survival for patients with multiple myeloma

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News